The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Adma Biologics Inc’s stock clocked out at $19.29, down -3.69% from its previous closing price of $20.03. In other words, the price has decreased by -$3.69 from its previous closing price. On the day, 6.64 million shares were traded. ADMA stock price reached its highest trading level at $19.98 during the session, while it also had its lowest trading level at $19.07.
Ratios:
To gain a deeper understanding of ADMA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 50.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 67.47. For the most recent quarter (mrq), Quick Ratio is recorded 2.80 and its Current Ratio is at 6.87. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.74.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 09 ’24 when Guiheen Lawrence P. sold 9,000 shares for $18.47 per share. The transaction valued at 166,189 led to the insider holds 153,941 shares of the business.
Guiheen Lawrence P. bought 9,000 shares of ADMA for $146,340 on Sep 09 ’24. On Aug 30 ’24, another insider, Kestenberg-Messina Kaitlin M., who serves as the COO and SVP, Compliance of the company, sold 24,150 shares for $16.90 each. As a result, the insider received 408,050 and left with 449,088 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 4496171520 and an Enterprise Value of 4549321728. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 137.20, and their Forward P/E ratio for the next fiscal year is 29.45. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.61 while its Price-to-Book (P/B) ratio in mrq is 23.88. Its current Enterprise Value per Revenue stands at 13.776 whereas that against EBITDA is 47.841.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $20.16, while it has fallen to a 52-week low of $3.06. The 50-Day Moving Average of the stock is 21.89%, while the 200-Day Moving Average is calculated to be 110.91%.
Shares Statistics:
It appears that ADMA traded 4.73M shares on average per day over the past three months and 10285260 shares per day over the past ten days. A total of 226.06M shares are outstanding, with a floating share count of 225.18M. Insiders hold about 3.39% of the company’s shares, while institutions hold 77.87% stake in the company. Shares short for ADMA as of 1724976000 were 9499242 with a Short Ratio of 2.01, compared to 1722384000 on 8746967. Therefore, it implies a Short% of Shares Outstanding of 9499242 and a Short% of Float of 4.2.
